
Something great is coming soon
Subscribe to get notified when our website is ready.
-
Racial Disparities in Naloxone Access
Image Link Overview Naloxone is an FDA approved medication used to undo overdose from prescription opioids, fentanyl, heroin, and other drugs (1). Naloxone has a reported success rate between 95-98%, making accessibility to the medication vital in the present U.S. overdose crisis (2).Naloxone is sold in pharmacies as a nasal spray, so all domestic populations should be able to easily discover and access the medication. However, there is inadequate Naloxone stock and distribution in areas heavily populated by racial minorities. This creates large racial disparities in Naloxone access, with Black, Latinx, and Indigenous populations having lower…
-
Having a Safe Release Standard from Prisons in the United States
The period immediately following release from incarceration represents a critical “cliff edge” for opioid overdose, with risk levels significantly higher than the general population. Despite known interventions, U.S. reentry remains fragmented, relying on discretionary programs rather than standardized clinical safeguards.
